Bath & Body Works (NYSE:BBWI) Issues FY25 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided EPS guidance of $3.06-3.26 for the period, compared to the consensus EPS estimate of $3.19. The company issued revenue guidance of down 2-4% yr/yr to ~$7.13-7.28 billion, compared to the consensus revenue estimate of $7.25 billion. Bath & Body Works also updated its Q3 guidance to $0.41-0.47 EPS.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $30.52 on Thursday. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The business has a 50 day simple moving average of $32.10 and a two-hundred day simple moving average of $40.46. The firm has a market capitalization of $6.69 billion, a PE ratio of 7.87, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Equities research analysts expect that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were paid a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.62%. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.62%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Barclays dropped their target price on Bath & Body Works from $32.00 to $31.00 and set an equal weight rating on the stock in a research report on Thursday, August 29th. Deutsche Bank Aktiengesellschaft decreased their price objective on Bath & Body Works from $57.00 to $54.00 and set a buy rating for the company in a report on Monday, August 26th. The Goldman Sachs Group decreased their price objective on Bath & Body Works from $60.00 to $49.00 and set a buy rating for the company in a report on Thursday, August 29th. Bank of America decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set a buy rating for the company in a report on Thursday, August 29th. Finally, BMO Capital Markets reiterated an outperform rating and set a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of Moderate Buy and an average target price of $43.00.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.